Schedule 13G ownership disclosure
ARROWHEAD PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 04280A100
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,563,132
- Percent of class
- 12.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000834237-21-002073
- Form type
- SC 13G
- Filer
- ARROWHEAD PHARMACEUTICALS, INC.
- CIK
- CIK 879407
- Filed
- Jan 27, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership